This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Masafumi Kitano: Innovator in Rho Kinase Inhibitors
Introduction
Masafumi Kitano is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Rho kinase inhibitors. His work is recognized for its potential impact on various medical conditions.
Latest Patents
Masafumi Kitano holds a patent for Rho kinase inhibitors, specifically a compound represented by the formula (1). This compound includes 1 to 4 R—X— groups that may be the same or different. His innovative approach in this area showcases his expertise and dedication to advancing medical science.
Career Highlights
Kitano is associated with Dainippon Sumitomo Pharma Co., Ltd., where he has been instrumental in research and development. His career reflects a commitment to improving therapeutic options through innovative solutions.
Collaborations
Throughout his career, Masafumi Kitano has collaborated with esteemed colleagues, including Naonori Imazaki and Naohito Ohashi. These partnerships have fostered a collaborative environment that enhances the quality of research and innovation.
Conclusion
Masafumi Kitano's contributions to the field of Rho kinase inhibitors exemplify his role as a leading inventor in pharmaceutical innovation. His work continues to inspire advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile